20May/13

Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or … – MarketWatch (press release)

Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or
MarketWatch (press release)
In this study, inotuzumab ozogamicin was administered on a once-a-month schedule in combination with rituximab and compared with an active comparator arm (investigator’s choice of bendamustine plus rituximab or gemcitabine plus rituximab). During a
Pfizer halts study of non-Hodgkin’s lymphoma drugBusinessweek
Pfizer (PFE) says it’s discontinuing Phase 3 studies on its investigational Seeking Alpha

all 4 news articles »

20May/13

Ginger Could Enhance Effects Of Asthma Medication, Study Finds – Huffington Post – Huffington Post

Ginger Could Enhance Effects Of Asthma Medication, Study Finds – Huffington Post
Huffington Post
journal, the results should be considered preliminary. But still, researchers write in the study abstract that “these compounds may provide additional relief of asthma symptoms when used in combination with beta-agonists and highlight novel use of

and more »